Susan Langer's most recent trade in Biogen Inc was a trade of 2,370 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen | Susan K. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 5,129 (0%) | 0% | 0 | Common Stock | |
| Biogen | Susan Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 2,759 (0%) | 0% | 0 | Common Stock | |
| Biogen | Susan Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 1,419 (0%) | 0% | 0 | Common Stock |